Cross-sectional internet survey exploring women's knowledge, attitudes and practice regarding urinary tract infection-related symptoms in the Netherlands.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
18 05 2022
Historique:
entrez: 18 5 2022
pubmed: 19 5 2022
medline: 21 5 2022
Statut: epublish

Résumé

Urinary tract infections (UTIs) are the most prevalent cause for women to consult a general practitioner (GP) and are commonly treated with (broad-spectrum) empirical antibiotics, even though 50% of UTIs are self-limiting. In this study, we aim to explore women's attitudes and experiences regarding UTIs, in order to determine patients' willingness to accept delayed antibiotic prescriptions. An internet-based cross-sectional survey SETTING: We recruited participants during 2 weeks of March and April in 2020 through several social media platforms. We obtained 1476 responses, of which 975 were eligible for analysis. We asked women about their knowledge, attitudes and practice regarding UTI-related symptoms. Participants ranked 'confirmation of diagnosis' (43.8%) as the most important reason to consult a GP with urinary symptoms, followed by 'pain relief' (32%), and 'antibiotic prescription' (14.3%). For treatment, 71% of participants reported that their GP prescribed immediate antibiotics, while only 3% received a delayed antibiotic prescription and 1% was advised pain medication. Furthermore, 50% of respondents were aware of the possible self-limiting course of UTIs and 70% would be willing to accept delayed antibiotic treatment, even if a certain diagnosis of UTI was established. Willingness to delay was lower in experienced patients compared to inexperienced patients. Women are quite receptive to delayed antibiotics as an alternative to immediate antibiotics for UTIs or urinary symptoms. GPs should consider discussing delayed antibiotic treatment more often with women presenting with urinary symptoms.

Identifiants

pubmed: 35584871
pii: bmjopen-2021-059978
doi: 10.1136/bmjopen-2021-059978
pmc: PMC9119184
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e059978

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Diagnostics (Basel). 2021 Mar 09;11(3):
pubmed: 33803202
BMJ. 2017 Nov 7;359:j4784
pubmed: 29113968
BMC Fam Pract. 2020 Nov 10;21(1):231
pubmed: 33172396
Evid Based Dent. 2006;7(1):24-5
pubmed: 16557257
J Antimicrob Chemother. 2018 Feb 1;73(suppl_2):ii2-ii10
pubmed: 29490062
Scand J Infect Dis. 2004;36(4):296-301
pubmed: 15198188
BMJ. 2015 Dec 23;351:h6544
pubmed: 26698878
Infect Dis (Lond). 2021 Feb;53(2):94-101
pubmed: 33073654
Scand J Prim Health Care. 2007 Mar;25(1):49-57
pubmed: 17354160
N Engl J Med. 1999 Dec 16;341(25):1906-12
pubmed: 10601511
Clin Microbiol Infect. 2017 Sep;23(9):647-652
pubmed: 28457846
Expert Rev Anti Infect Ther. 2020 Jan;18(1):47-61
pubmed: 31795788
Fam Pract. 2014 Apr;31(2):149-55
pubmed: 24317602
J Am Geriatr Soc. 2014 Apr;62(4):696-705
pubmed: 24635138
Br J Gen Pract. 2002 Sep;52(482):729-34
pubmed: 12236276
BMJ. 2010 Feb 05;340:c199
pubmed: 20139214
Eur J Epidemiol. 2006;21(2):103-11
pubmed: 16518678
NPJ Prim Care Respir Med. 2016 Feb 04;26:15083
pubmed: 26845640
Br J Gen Pract. 2015 Oct;65(639):e702-7
pubmed: 26412847
Antibiotics (Basel). 2016 Aug 15;5(3):
pubmed: 27537922
BMC Fam Pract. 2013 May 31;14:71
pubmed: 23721260
PLoS Med. 2018 May 15;15(5):e1002569
pubmed: 29763434
Br J Gen Pract. 2014 Jan;64(618):e10-6
pubmed: 24567577
Arch Intern Med. 2002 Mar 11;162(5):600-5
pubmed: 11871930
BMJ. 2010 Feb 05;340:c279
pubmed: 20139217
Urology. 2020 Feb;136:119-126
pubmed: 31715272
BMC Med. 2010 May 26;8:30
pubmed: 20504298
BMJ Open. 2019 May 19;9(5):e027221
pubmed: 31110099

Auteurs

Stefan Martinus Leonardus Cox (SML)

General Practice, Maastricht University, Maastricht, The Netherlands s.cox@maastrichtuniversity.nl.

Minke W E M van Hoof (MWEM)

General Practice, Maastricht University, Maastricht, The Netherlands.

Kelly Lo-A-Foe (K)

General Practice, Maastricht University, Maastricht, The Netherlands.

Geert-Jan Dinant (GJ)

General Practice, Maastricht University, Maastricht, The Netherlands.

Guy J Oudhuis (GJ)

Medical Microbiology, Maastricht University Medical Centre+, Maastricht, The Netherlands.

Paul Savelkoul (P)

Medical Microbiology, Maastricht University Medical Centre+, Maastricht, The Netherlands.

Jochen W L Cals (JWL)

General Practice, Maastricht University, Maastricht, The Netherlands.

Eefje G P M de Bont (EGPM)

General Practice, Maastricht University, Maastricht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH